Pre-conception planning, anti-epileptic medication risks, and why detailed seizure logs matter for obstetric care. Navigate epilepsy in pregnancy with UK medical guidance.
Planning pregnancy with epilepsy requires careful preparation and close coordination with both your neurologist and obstetric team. The good news is that most women with epilepsy have healthy pregnancies and deliver healthy babies. But it does require planning, and one of the most valuable things you can bring to that planning process is a well-documented seizure history. Understanding your baseline seizure frequency, patterns, and medication response before pregnancy starts makes informed decisions possible.
Ideally, women with epilepsy should plan pregnancy in consultation with their neurologist at least three to six months before attempting to conceive. This appointment should cover several key topics:
This conversation is easier and more detailed if you have several months of seizure logs documenting your baseline frequency, patterns, and how your current medication is working.
Most AEDs are compatible with pregnancy, but some carry higher teratogenic risk than others. Valproate (sodium valproate, valproic acid) is particularly concerning — it carries a significantly higher risk of birth defects and developmental disorders in the baby if exposed in utero, particularly in the first trimester. The NICE guidelines and UK Epilepsy and Pregnancy Register both recommend that women of childbearing age should not be started on valproate unless no suitable alternatives exist, and ideally should be switched to a safer alternative before conception.
Other AEDs with lower teratogenic risk in pregnancy include lamotrigine and levetiracetam. However, pregnancy itself alters the metabolism of some AEDs — particularly lamotrigine and potentially others — meaning blood levels can drop significantly during pregnancy as your body weight increases and metabolic clearance changes. This can lead to breakthrough seizures if doses aren't adjusted. Regular monitoring of drug levels and seizure frequency during pregnancy is important.
The key principle is that uncontrolled seizures during pregnancy carry significant risk to both mother and baby, including risks of stillbirth, premature labour, and physical injury during a seizure. The goal is to balance the teratogenic risk of medication against the maternal and fetal risks of uncontrolled seizures. This is why documentation of your baseline control matters — it shows your doctor whether you need high-level coverage.
Your obstetrician needs to understand your seizure history and current control because this informs pregnancy management, delivery planning, and postpartum care. A woman who averages two seizures per month on her current regimen presents a different risk profile than a woman who has been seizure-free for two years. Your obstetrician may recommend:
Arriving at your obstetric booking appointment with three to six months of documented seizure frequency and patterns allows these conversations to be specific and evidence-based rather than based on assumptions about epilepsy in general.
The UK Epilepsy and Pregnancy Register is a confidential registry that tracks outcomes of pregnancies in women with epilepsy taking various medications. Registering yourself allows your care team to contribute anonymised outcome data that helps inform future guidance for other women. It also ensures that if concerns emerge about a particular medication, you can be contacted. Registration is free and can be done at your neurology appointment or online.
Seizure control can change in either direction during pregnancy. About one-third of women have worse control, one-third have better control, and one-third remain the same. This is unpredictable. Some women find that their seizures improve significantly during pregnancy (possibly due to consistent medication compliance, stable sleep, and hormonal factors), whilst others experience breakthrough seizures despite optimised dosing.
This is why seizure logging becomes even more important during pregnancy. Your neurologist needs to know if seizure frequency is changing so they can adjust medication or dosing as needed. Monthly or fortnightly seizure frequency reviews with your neurologist during pregnancy are often recommended, and your logged data is essential for these conversations.
Most AEDs pass into breast milk to some degree, but the amounts are usually small enough that breastfeeding is compatible with most medications and is generally encouraged. However, some AEDs (particularly phenobarbital and benzodiazepines) accumulate more significantly in breast milk. Your neurologist can advise on safe breastfeeding with your specific medication. Breastfeeding decisions should be made in discussion with your maternity team and neurologist.
Tip: Start keeping a detailed seizure diary at least three months before attempting pregnancy. Include date, time, seizure type, recovery time, and any potential triggers. This baseline data is invaluable for your neurologist in planning pre-conception medication adjustments, and for your obstetrician in understanding your pregnancy risk. Continue logging throughout pregnancy — monthly seizure frequency reports are more useful to your medical team than trying to recall patterns from memory.
Your medication needs may change again after delivery — stress, sleep disruption from newborn care, and hormonal shifts postpartum can all affect seizure control. Some women need dosage increases postpartum to maintain the control they had during pregnancy. Regular monitoring in the first few months after delivery is advisable.
Epilepsy and pregnancy can be successfully managed with careful planning, good communication between your medical teams, and documentation of your seizure patterns. The result is safe pregnancy and delivery for you and your baby.
One-tap logging, automatic timestamps, PDF reports for your GP, and shared access for family and carers — all in one place.
Get Seizure Tracker →